MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, June 8, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medline Inc. ("Medline" or "the Company") (NASDAQ: MDLN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

PRNewsWire • 17 hours ago

Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON MEDLINE INDUSTRIES, INC. (MDLN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On June 2, 2026, the FDA published a warning letter address.

Business Wire • 13 hours ago

Primary Markets Group May 2026 U.S. IPO Monthly

The U.S. IPO market maintained its strong momentum in May with 12 offerings raising $13.1 billion in total proceeds, which was well above April's $8.2 billion in total proceeds but one short on deal count. The largest deal of the month was technology firm Cerebras Systems' $6.4 billion raise, making it the largest IPO since Medline Inc.'s $7.2 billion raise in December 2025 and the biggest tech IPO since Uber Technologies' $8.1 billion in May 2019. The healthcare sector saw three new issuers, led by GMR Solutions' $478.7 million offering.

Seeking Alpha • Jun 7, 2026

Medline draws another US FDA warning in two months over quality lapses

The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, ​the second such action against the company in two ‌months.

Reuters • Jun 3, 2026

Medline Inc. (MDLN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Medline Inc. (MDLN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Seeking Alpha • Jun 3, 2026

Medline's Prime Vendor model expands outside the United States

Agreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S. NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States.

PRNewsWire • May 29, 2026

Medline Inc. announces closing of upsized secondary offering of Class A common stock

NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock.

GlobeNewsWire • May 28, 2026

Medline announces participation in upcoming investor conferences

NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences.

GlobeNewsWire • May 27, 2026

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

EscharEx ® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd.

GlobeNewsWire • May 27, 2026

Medline Inc. announces pricing of upsized secondary offering of Class A common stock

NORTHFIELD, Ill., May 21, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. The offering is expected to close on May 28, 2026, subject to customary closing conditions.

GlobeNewsWire • May 22, 2026